Second line medication for Crohn's disease

RX_CROHN_2NDLINE

No definition available.

Endpoint definition

FinnGen phenotype data

392423 individuals

diagram downward connector

Apply sex-specific rule None

392423

diagram downward connector

Check conditions None

392423

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, registry filters

Medicine purchases: ATC L04AX|L01BB02

1 out of 7 registries used, show all original rules.

20984

diagram downward connector
diagram bullet

Check minimum number of events

Min. number of events 3

20984

diagram downward connector

Include endpoints None

20984

diagram downward connector
diagram bullet diagram downward connector

Remove individuals based on genotype QC

20353

diagram downward connector
RX_CROHN_2NDLINE

Control definitions

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze DF5

Summary Statistics

Key figures

All Female Male
Number of individuals 20353 12587 7766
Unadjusted prevalence (%) 5.40 5.97 4.67
Mean age at first event (years) 50.56 49.48 52.29

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.03 2.16 [1.71, 2.73] 8.2e-11 1201
15 years 0.01 1.41 [1.13, 1.75] 2.2e-3 633
5 years 0.00 2.78 [2.31, 3.35] 4.4e-27 377
1 year 0.00 3.07 [2.33, 4.04] 1.8e-15 75

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

Index endpoint: RX_CROHN_2NDLINE – Second line medication for Crohn's disease
GWS hits: 29

Survival analyses between endpoints

Plot

before Second line medication for Crohn's disease
after Second line medication for Crohn's disease

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Second line medication for Crohn's disease

Endpoint not on priority list, no data to show.